[chart]investorshub.advfn.com/uimage/uploads/2017/6/28/lmzwbrabits.jpg[/chart]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
George has teamed up with Lingerie Fighting Championships League to keep their junk from flopping out during a fight. LOL
GRDO..Yes George is doing it by the book. Dog will stay current.
GRDO..03/29/2019 Notification of Late Filing - Notification of Late Filing 12/31/2018
https://www.otcmarkets.com/stock/GRDO/disclosure
NEWS OUT Press Release: Creative Medical Technology Holdings, Inc. March 28, 2019 Shareholder UpdateprintFont size A A A
10:25 AM ET 3/28/19 | Dow Jones
Creative Medical Technology Holdings, Inc. March 28, 2019 Shareholder Update
PR Newswire
PHOENIX, March 28, 2019
PHOENIX, March 28, 2019 /PRNewswire/ -- (OTCQB-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of its activities:
CaverStem(TM) domestic activities: As previously reported, we are continuing marketing to physicians across the United States. Since our last shareholder update several physicians have joined CaverStem(TM) and are in the process of training and patient acquisition.
We have added physicians in Hawaii, California, Ohio, Texas and Tennessee. We will continually add the new physicians to the CaverStem(TM) website, begin the patient awareness campaign in each area and schedule physician training.
These physicians came to us through our physician marketing program as previously disclosed. We are continuing to use this marketing tool with mailers and emails with follow up personal or telephone communication with physicians across the country.
We are always working to get physicians trained as soon as possible. In order to properly train each physician, we require a minimum of 5 patients. This requires scheduling all patients, the physician and our trainer. This process has caused delays, therefore we have added additional medical personnel to travel to each physicians office to train. With this increased flexibility on our part we anticipate a reduction in such delays.
As previously disclosed, our patient marketing campaign has relied heavily on social media with the use of Google Ad Words and banner advertising. We believe social media is a great resource as 80% of patients find us, using their phones and tablets. In order to continue to grow patient awareness print advertising is now being used and we are continuing to develop our television commercial which will be edited to direct patients to each physician in their area.
CaverStem(TM) International: We have successfully treated our first six patients in Italy and other patients are scheduled. Due to the increased international demand and to compliment our existing relationship with Scott Shea, CEO of Aspire Medical in Munich, Germany with whom we enjoy a phenomenal relationship, Thomas Bianchi has joined the company as our international sales representative. Mr. Bianchi has decades long experience in medical device sales, having worked for companies such as Stryker and Medtronics. With Scott and Thomas on the CaverStem(TM) team we expect to continue to grow our international physician base not only in recruiting new physicians but in more effectively servicing existing physicians.
Progress in Russia has been much slower than expected. Government exemptions are required for the ongoing import of our device. This is a slow and tedious process in getting approval, therefore our progress has been delayed. We will continue with this process and maintain great faith in our relationship with Promo Med and our expansion in to this sizable market.
CaverStem(TM) clinical trial: As we've previously advised, we are working on our paper for publication. This is ongoing and in compliance with our contractual obligations. Once our paper has been approved by The Journal of Translational Medicine and a publication date advised we will advise.
Additionally, we have designed an electronic patient registry that is intended to include data from our clinical trial, data from treating physicians using centrifuge technology with a 30cc to 60cc bone marrow aspiration and our second generation, needle only, mini bone marrow aspiration technology drawing a maximum of 20cc of bone marrow. Recent publications have disclosed that with the second generation needle technology a larger amount of pure cell product is harvested because of a reduction in dilution of blood, thus requiring a reduced bone marrow aspiration. The registry will enable the company to gather and maintain ongoing HIPAA compliant information on patient demographics, history and treatment progress. Patient names and addresses will not be included on the registry or disclosed to the company.
We have received positive feedback from treating physicians of a 70% to 90% efficacy in their patients. Obviously results differ depending on the age and health of the patient and cause and severity of their erectile dysfunction.
FemCelz(TM): As previously announced, we are progressing with the development of the FemCelz(TM) procedure for the treatment of female sexual dysfunction.
Our progress in Q1 has included;
1. Development of the protocol.
2. Distribution of protocol to numerous physicians.
3. Scheduling of the first patients for treatment.
4. Ongoing design of the FemCelz website, to be launched in early April.
5. Design of social media campaign towards female patients.
6. Marketing to physicians in this space.
Expanding exposure of the company: We recently released a corporate video for the purpose of expanding recognition of the company to multiple groups including the financial and medical sectors. We will continue to utilize all legal means of increasing awareness of CELZ and its technologies. To increase shareholder value.
We are currently finalizing the 10k with our CPA, attorneys and PCAOB accountants.
About Creative Medical Technology Holdings
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company currently trading on the OTCQB under the ticker symbol CELZ. For further information about the company go to www.creativemedicaltechnology.com. For more information on our CaverStem(TM) procedure please go to www.caverstem.com.
Forward-Looking Statements
OTC Markets has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming clinical trials and laboratory results, marketing efforts, funding, etc. Forward-looking statements address future events and conditions and, therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website at www.sec.gov.
View original content:http://www.prnewswire.com/news-releases/creative-medical-technology-holdings-inc-march-28-2019-shareholder-update-300820339.html
SOURCE Creative Medical Technology Holdings, Inc.
/CONTACT: Timothy Warbington, Chief Executive Officer, Tel: (480) 789-9939
/Web site: http://www.creativemedicaltechnology.com
> Dow Jones Newswires
March 28, 2019 10:25 ET (14:25 GMT)
12 ReTech Announces the Launch of its New 12Europe Website in Support of Jelmolis Launch of the 12 Sconti APP.printFont size A A A
9:00 AM ET 3/28/19 | GlobeNewswire
12 ReTech Announces the Launch of its New 12Europe Website in Support of Jelmoli's Launch of the 12 Sconti APP.
Las Vegas, NV, Hong Kong & Zurich, Switzerland, March 28, 2019 (GLOBE NEWSWIRE) -- 12 ReTech Corporation (OTC: RETC) announced today that it has launched its new revamped 12 Europe AG website to support the new Jelmoli implementation of the Company's 12 Sconti APP which is due to launch in the next few days. Those who are interested can visit the website at www.12europe.com. The main website is in English for the international and investing community while the 12 Sconti tab goes directly to 12sconti.com which is written entirely in German to support Jelmoli's 12 Sconti product offerings in Switzerland.
The 12 Europe website features two main products; 12 Sconti and 12 Visore.
Now that Switzerland's Jelmoli, known as the "House of Brands", has integrated the 12Sconti APP into its operations, they have begun promoting the benefits of this new marketing tool to their customers. Their customer database contains around one million shoppers loyal to the Jelmoli brand. Their customers are being encouraged to download the 12Sconti APP by a comprehensive local public relations campaign. The first activities will happen next week with a Jelmoli Press Release sent to more than 60 major Swiss publications.
Jelmoli will use the 12 Sconti APP to advertise daily specials that its business units want to put in front of customers who find themselves in the vicinity of that business unit. 12 Sconti is an ecology-friendly mobile application that seeks to prevent food spoilage and waste. Each merchant like Jelmoli donates 1% of their 12Sconti sales receipts to the charity of their choice. Like our other APPs, 12Sconti offers retailers a marketing platform independent of Google, Facebook or Instagram, to reach potential customers in the vicinity and attract them to their stores.
Angelo Ponzetta, 12 ReTech's CEO commented, "We started the 12Sconti project in May 2018 in collaboration with The Hunger Project in Winterthur, Switzerland, but without the support of a major retailer like Jelmoli, the adoption by both local retailers and users was slower than we had expected."
Mr. Ponzetta continued, "However now, with Jelmoli on-board, we have a proposition that will make sense to the Zurich population. Jelmoli will use their in-house database in conjunction with a well-conceived public relations campaign to drive downloads of the 12Sconti APP. Jelmoli's goal is to offer to nearby customers vacant restaurant tables and products like bakery goods with limited shelf lives for immediate purchase at discounted prices."
Mr. Ponzetta finished, "With our recently acquired operations in the USA and with the further progress of Jelmoli, I truly believe that our business operations are now very much improved in comparison with previous years. I look forward to announcing additional progress on our path to increased shareholder value."
About Jelmoli:
With a history dating back to 1833, Switzerland's leading premium department store offers exclusive international and Swiss brands on six floors. Over 2 million items from more than 1,000 brands are displayed for a diverse and demanding clientele on around 24,000 square meters of space divided across the six stories. Over 1,000 qualified employees create an atmosphere of well-being, high-quality advice and a positive shopping experience.
About 12 ReTech Corporation:
At our core, we are a software company whose technology allows retailers to combat the dual threats of Walmart and Amazon -- both online and in physical stores. Our microbrand rollup acquisition strategy allows us to demonstrate the effectiveness of our software, devise and test new products, while providing shareholder value through immediate revenue and earnings growth. The Company operates through our subsidiaries on three continents: 12 Hong Kong, Ltd., 12 Japan, Ltd., 12 Europe A.G., 12 Retail Corporation (and its subsidiaries in North America, including Emotion Fashion Group, Inc., Red Wire Group, LLC and Rune NYC, LLC). For more information please visit our website at www.12ReTech.com.
12 ReTech Corporation is publicly listed on the OTC Markets under the symbol RETC.
Safe Harbor: This document contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect, " "believe," and similar expressions are intended to be forward-looking statements.
Investors Relations Contacts:
Mark Gilbert
Magellan FIN, LLC
mgilbert@magellanfin.com
317-361-2392 (USA)
Corporate Headquarters
investors@12ReTech.com
> Dow Jones Newswires
March 28, 2019 09:00 ET (13:00 GMT)
GRDO Nice green Day Huge bid and No one selling, colloid tight for blast off^^
PHIL Plus New 8-K Pr out in the last hour.
PHIL 8-K out
ALKM Next stop The Moon^^
Sounds good. We all know it will be out soon.
Q Last year went like this. Doesn't mean this year will be the same.
4/16/2018 15:07 EDGAR Annual Report (10-k)
3/30/2018 15:32 EDGAR Notification That Annual Report Will Be Submitted Late (nt..
News...3/25/2019...PHI Group, Inc. Announces Stock Repurchase ProgramFo
9:00 AM ET 3/25/19 | GlobeNewswire
PHI Group, Inc. Announces Stock Repurchase Program
New York, March 25, 2019 (GLOBE NEWSWIRE) -- PHI Group, Inc. (www.phiglobal.com) (OTCMarkets: PHIL), a U.S. diversified holding company focused on mergers and acquisitions and investments in select industries and special situations, today announced that the Company has approved a program to buy back its common stock from the open market from time to time in accordance with the following terms:
1. Purpose of Repurchase: To enhance future shareholder returns.
2. Details of Repurchase:
a. Class of shares to be repurchased:Common Stock of PHI Group, Inc.
b. Total number of repurchasable shares: 5.3 billion shares, or more as may be needed.
c. Total repurchase amount: To be determined by prevalent market prices at times of transaction.
d. Method of repurchase: Open market purchase.
e. Repurchase period: April 15, 2019 to March 13, 2020.
3. Remarks:
a. PHI Group, Inc. will fund the proposed share repurchase program with the proceeds from the disposal of a portion of certain
non-core assets and from future earnings of the Company.
b. The share repurchase program will be in full compliance with state and federal laws and certain covenants with the Company's note-holders.
Henry Fahman, Chairman and CEO of PHI Group, said: "The Company has been primarily focused on developing very special initiatives and programs, such as the Luxembourg bank funds and the Asia Diamond Exchange in the Free Trade Zone of the Chu Lai Open Economic Zone, Quang Nam Province, Vietnam, that are expected to yield very significant long-term value for our shareholders. We believe it is in the best interest of the company and our shareholders that we repurchase as many shares of our common stock as possible from the open market as outlined in the above-mentioned buy-back program."
About PHI Group
PHI Group (www.phiglobal.com) primarily focuses on mergers and acquisitions and invests in select industries and special situations that may substantially enhance shareholder value. In addition, the Company's wholly owned subsidiary, PHI Capital Holdings, Inc. (www.phicapitalholdings.com) provides M&A consulting services and assists companies to go public and access international capital markets. We have also been working diligently to launch PHILUX Global Funds with several subfund compartments for investment in renewable energy, agriculture, real estate and a diamond exchange center in Vietnam together with reputable international advisers and partners.
Safe Harbor Act and Forward-looking Statements
This news release contains "forward-looking statements" pursuant to the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected," which are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements as a result of various factors.
Contact:
PHI Group, Inc.
+1-702-475-5430
info@phiglobal.com
> Dow Jones Newswires
March 25, 2019 09:00 ET (13:00 GMT)
Creative Medical Technology Holdings Inc.
4 hrs ·
CaverStem technology gains recognition on Philippine TV.
(1:42 mark)
https://www.untvweb.com/fu…/good-morning-kuya-march-21-2019/
RETC We good here Just needs to get some momentum to start the climb and wipe out the flippers. :)
GRDO. George large and in charge. Stay tuned for Biz plan with profitable venture.
RETC LOL only 14% when my steel stock went up 52 cents and only 2.6%
GRDO only 300k sells all day.
Alps dumped his last at 7 and went up to 10. On 8-K wach time to go up :)
RETC 8's thin as hot butter spread on a toasted english muffin. :)
RETC Do we get the 8-K tonight or tomorrow?
CELZ, News with the 10-K by end of month. Hold on tight, lets gogoggogogo. :)
Anyone see the Ihub CELZ add,
FEATURED VIDEOS? http://www.creativemedicaltechnology.com/
RETC News 3/18/2019....12 ReTech Completes 3rd Fashion Brand Acquisition Rune NYC, LLC becomes a 12 ReTech Subsidiary
9:00 AM ET 3/18/19 | GlobeNewswire
12 ReTech Completes 3rd Fashion Brand Acquisition Rune NYC, LLC becomes a 12 ReTech Subsidiary
Las Vegas, NV & Hong Kong, March 18, 2019 (GLOBE NEWSWIRE) -- 12 ReTech Corporation (OTC: RETC) announced today that it has acquired 92.5% ownership of Rune NYC, LLC ("RUNE"). As a result, we expect to consolidate RUNE's financials into our own SEC financial reports beginning with the upcoming 1(st) Quarter, FY2019 FORM 10-Q due in May of 2019.
RUNE is an up and coming women's apparel brand that already sells their activewear products through a variety of well-known domestic USA sales and distribution channels. This acquisition brings immediate brand awareness and revenues to 12 ReTech. Management expects to increase RUNE's annual revenues which have recently been as high as $1.4 million and even though 2018 revenues were approximately $800 thousand, management expects the next 12 months of operations to yield at least $1.2 million in profitable sales as we grow RUNE's customer base and increase their gross margins by shifting production to Red Wire Group, LLC's apparel manufacturing facility, which recently became a wholly owned subsidiary of our Company.
Angelo Ponzetta, 12 ReTech's CEO commented, "RUNE is an exciting addition to our portfolio of women's apparel brands. There is good demand for their apparel and they bring new ideas to market quickly. Synergistically, our Red Wire Group manufacturing operations will help to improve RUNE's operating margins. In addition, RUNE's existing sales channels will be a great place to introduce our other brands to. I am positive that with our assistance, over the next year RUNE will be generating record revenue run rates for our Company."
Greg Haehl, manager of the Company's manufacturing operation- Red Wire Group commented, "Since the signing of the Definitive Agreement between the Company and RUNE, Red Wire has already been manufacturing RUNE's products. So far, we have demonstrated. quick turnaround and cost savings for RUNE. We welcome Emily to our team and are excited to work with her and the RUNE team."
Emily Santamore, Managing Member of Rune NYC commented, "I am thrilled to join the 12 ReTech team. Since RUNE's inception, I have developed a sizable following for my brand and believe that 12 ReTech will help me gather more RUNE fans quickly. The obvious synergies that 12 ReTech's subsidiaries bring to the table will help me to concentrate my time on where it is best spent, in apparel design and sales, which will benefit all our 12 ReTech brands. With the lower costs of Red Wire's manufacturing, I should be able to win business from large brand name retailers who have expressed interest in my designs but for whom I was previously unable to meet their pricing requirements. This should really accelerate our revenue growth."
Ms. Santamore continued, "In addition, I have several C-level contacts in the department store and retail industries and have started to introduce the 12 ReTech technology to my customers. They have provided some very positive responses and we will soon be proposing 12 ReTech's technology alongside Rune's apparel offerings to build value for my most progressive customers."
Angelo Ponzetta added "We are already working on the integration of our three fashion brands, with Red Wire's team operating the manufacturing for our brands in two factory sites. This is an exciting time for our Company as our recent additions are producing positive cash flow and opening new opportunities for us in both our technology business and our consumer brand business. There is a lot going on in our business pipeline in all three of our geographic markets, Soon, I hope to present exciting news about technology progress in Europe and the USA."
Mr. Ponzetta finished, "We are really starting to gain momentum!"
About Rune NYC, LLC
Founded by a brother-sister team in January 2013, Rune NYC, LLC set up shop in the heart of New York City's historic garment district. Rune NYC is a growing fashion company focusing on the expanding women's market of activewear and athleisure. They offer an array of apparel targeted to fashionable women who are looking for excellent quality and great value. Rune currently designs and produces fashion leggings, maternity leggings, plus-size leggings, bottoms, tops, dresses, and jackets. Rune NYC is 100% designed and manufactured in the USA.
About 12 ReTech Corporation:
At our core, we are a software company whose technology allows retailers to combat the dual threats of Walmart and Amazon -- both online and in physical stores. Our microbrand rollup acquisition strategy allows us to demonstrate the effectiveness of our software, devise and test new products, while providing shareholder value through immediate revenue and earnings growth. The Company operates through our subsidiaries on three continents: 12 Hong Kong, Ltd., 12 Japan, Ltd., 12 Europe A.G., 12 Retail Corporation (and its subsidiaries in North America, including Emotion Fashion Group, Inc., Red Wire Group, LLC and Rune NYC, LLC). For more information please visit our website at www.12ReTech.com.
12 ReTech Corporation is publicly listed on the OTC Markets under the symbol RETC.
Safe Harbor: This document contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect, " "believe," and similar expressions are intended to be forward-looking statements.
Investors Relations Contacts:
Mark Gilbert
Magellan FIN, LLC
mgilbert@magellanfin.com
317-361-2392 (USA)
Corporate Headquarters
investors@12ReTech.com
> Dow Jones Newswires
March 18, 2019 09:00 ET (13:00 GMT)
ALKM To the da Moon .0088 at least. :)
CELZ..We can't predict the future, I can only post what happened last year. :)
Celz...Q-1 went like this last year..
5/21/2018 16:45 EDGAR Quarterly Report (10-q)
5/14/2018 16:32 EDGAR Notification That Quarterly Report Will Be Submitted Late..
CELZ 1st we get 10-K end of the month..Last year came out 3/29/2018 16:28 EDGAR Annual Report (10-k)
Q-1 went like this last year:
5/21/2018 16:45 EDGAR Quarterly Report (10-q)
5/14/2018 16:32 EDGAR Notification That Quarterly Report Will Be Submitted Late..
BYSD We should get a filing and News soon. :)
CELZ MJ stem cells to keep your plant from wilting? LOL
CELZ...Caverstem
3 mins ·
Watch for our monthly newsletter at caverstem.com
MAXM Killing the Vibe. :)
GRDO..Love it Blockers are getting slapped to smithereens. :)
GRDO .0015 sellers getting smoked and losing valuable shares. :)
RETC There hasn't been any in a long time. Go RETC :)
RETC..Entity Actions for "12 RETECH CORPORATION"
Sort by descendingascending order
1 - 17 of 17 actions
Actions\Amendments
Action Type: Amendment
Document Number: 20190108183-93 # of Pages: 1
File Date: 3/8/2019 Effective Date:
Previous Stock Value: Par Value Shares: 1,000,000,000 Value: $ 0.00001 Par Value Shares: 50,000,000 Value: $ 0.00001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 10,500.00 New Stock Value: Par Value Shares: 8,000,000,000 Value: $ 0.00001 Par Value Shares: 50,000,000 Value: $ 0.00001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 80,500.00
https://www.nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=0qPcx5eKGABOKC5Bx%252bL1Qg%253d%253d&CorpName=12+RETECH+CORPORATION
RETC...Reality is the shares have to come from here 1st and there are not 7 billion new shares.
https://www.nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=0qPcx5eKGABOKC5Bx%252bL1Qg%253d%253d